کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
1948196 | 1054678 | 2009 | 16 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Cancer cell iron metabolism and the development of potent iron chelators as anti-tumour agents
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
Fpn1HREVHLIRPDPTDesferrioxaminePIHIRETfR1CDKferroportin1BPTG6PDHCDKIDp44mT2-benzoylpyridine thiosemicarbazoneHcp1311DMT1Gadd45MMPHIF-1αTransferrinDFOLIPHFEROS - ROSWAF1 - WAF 1Iron - آهنiron-regulatory protein - آهن پروتئینی نظارتیVon Hippel–Lindau - از Hippel-LindauLabile iron pool - استخر چربdivalent metal ion transporter 1 - حمل کننده 1 یون فلز متخلخلRibonucleotide reductase - ریبونوکلئوتید ردوکتازhypoxia inducible factor-1α - عامل القایی هیپوکسی 1αiron-responsive element - عنصر پاسخ دهنده آهنhypoxia response element - عنصر پاسخ هیپوکسیmatrix metalloproteinase - ماتریکس متالوپروتئینازUTR یا untranslated regions - منطقه ترجمه نشدهuntranslated region - منطقه غیر ترجمهcyclin-dependent kinase inhibitor - مهار کننده کیناز وابسته به سیکلینretinoblastoma protein - پروتئین رتینوبلاستوماPyridoxal isonicotinoyl hydrazone - پییریدکسال ایزونیکوتینویل هیدرازونcyclin-dependent kinase - کییناز وابسته به سیکلینglucose-6-phosphate dehydrogenase - گلوکز 6-فسفات دهیدروژنازReactive oxygen species - گونههای فعال اکسیژنtransferrin receptor - گیرنده انتقالینtransferrin receptor 1 - گیرنده پروتئین 1
موضوعات مرتبط
علوم زیستی و بیوفناوری
بیوشیمی، ژنتیک و زیست شناسی مولکولی
زیست شیمی
پیش نمایش صفحه اول مقاله
چکیده انگلیسی
Cancer contributes to 50% of deaths worldwide and new anti-tumour therapeutics with novel mechanisms of actions are essential to develop. Metabolic inhibitors represent an important class of anti-tumour agents and for many years, agents targeting the nutrient folate were developed for the treatment of cancer. This is because of the critical need of this factor for DNA synthesis. Similarly to folate, Fe is an essential cellular nutrient that is critical for DNA synthesis. However, in contrast to folate, there has been limited effort applied to specifically design and develop Fe chelators for the treatment of cancer. Recently, investigations have led to the generation of novel di-2-pyridylketone thiosemicarbazone (DpT) and 2-benzoylpyridine thiosemicarbazone (BpT) group of ligands that demonstrate marked and selective anti-tumour activity in vitro and also in vivo against a wide spectrum of tumours. Indeed, administration of these compounds to mice did not induce whole body Fe-depletion or disturbances in haematological or biochemical indices due to the very low doses required. The mechanism of action of these ligands includes alterations in expression of molecules involved in cell cycle control and metastasis suppression, as well as the generation of redox-active Fe complexes. This review examines the alterations in Fe metabolism in tumour cells and the systematic development of novel aroylhydrazone and thiosemicarbazone Fe chelators for cancer treatment.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Biochimica et Biophysica Acta (BBA) - General Subjects - Volume 1790, Issue 7, July 2009, Pages 702-717
Journal: Biochimica et Biophysica Acta (BBA) - General Subjects - Volume 1790, Issue 7, July 2009, Pages 702-717
نویسندگان
D.R. Richardson, D.S. Kalinowski, S. Lau, P.J. Jansson, D.B. Lovejoy,